Literature DB >> 9299632

Mutagenesis of a cAMP response element within the latency-associated transcript promoter of HSV-1 reduces adrenergic reactivation.

D C Bloom1, J G Stevens, J M Hill, R K Tran.   

Abstract

Mutagenesis of a cyclic AMP response element (CRE) within the LAT promoter of HSV-1 reduces the ability of LAT expression to be induced in transient assays, but has only a minimal impact on reactivation of the virus in in vitro systems. Here we show that a CRE mutation results in a significant reduction of adrenergically induced reactivation in vivo in the rabbit eye model. Spontaneous reactivation frequencies were also reduced. In addition, we demonstrate that this mutation has no effect on the amount of LAT expressed during latency when compared with the parent, 17syn+, and the rescuant. These results indicate a greater effect of CRE on induced reactivation in vivo than in in vitro systems, but also suggest that the CRE in the LAT promoter is not autonomous in conducting the reactivation signal. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299632     DOI: 10.1006/viro.1997.8723

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Clues to mechanisms of herpesviral latent infection and potential cures.

Authors:  David M Knipe; Priya Raja; Jennifer S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

2.  Stress Hormones Epinephrine and Corticosterone Selectively Modulate Herpes Simplex Virus 1 (HSV-1) and HSV-2 Productive Infections in Adult Sympathetic, but Not Sensory, Neurons.

Authors:  Angela M Ives; Andrea S Bertke
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Potential role for luman, the cellular homologue of herpes simplex virus VP16 (alpha gene trans-inducing factor), in herpesvirus latency.

Authors:  R Lu; V Misra
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 5.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

6.  Inducible cyclic AMP early repressor produces reactivation of latent herpes simplex virus type 1 in neurons in vitro.

Authors:  M A Colgin; R L Smith; C L Wilcox
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.

Authors:  Margaret Chang; Helen J Brown; Alicia Collado-Hidalgo; Jesusa M Arevalo; Zoran Galic; Tonia L Symensma; Lena Tanaka; Hongyu Deng; Jerome A Zack; Ren Sun; Steve W Cole
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.

Authors:  Guey-Chuen Perng; Clinton Jones
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-15

9.  Role of activating transcription factor 3 in the synthesis of latency-associated transcript and maintenance of herpes simplex virus 1 in latent state in ganglia.

Authors:  Minfeng Shu; Te Du; Grace Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

Review 10.  Herpes simplex virus type 1 and bovine herpesvirus 1 latency.

Authors:  Clinton Jones
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.